Prevest Denpro Ltd Stock Price Today (NSE: PREVEST)
Fundamental Score
Prevest Denpro Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Prevest Denpro Ltd share price today is ₹462.00, up +0.00% on NSE/BSE as of 19 February 2026. Prevest Denpro Ltd (PREVEST) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹521.17 (Cr). The 52-week high for PREVEST share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 26.18x, PREVEST is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 18.74% and a debt-to-equity ratio of 0.00.
Prevest Denpro Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Prevest Denpro Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Prevest Denpro Share Price: A ROCE-Focused Analysis
The medical equipment and supplies industry is experiencing a period of rapid innovation, driven by demand for minimally invasive procedures and personalized healthcare solutions. This heightened competition places a premium on companies that can efficiently allocate capital and generate superior returns. This analysis examines the Prevest Denpro share price, currently at ₹455.0, focusing on Return on Capital Employed (ROCE) as a key indicator of efficiency and competitive advantage. The company's Price-to-Earnings (PE) ratio stands at 26.18, while its ROCE is reported as 25.25%.
A ROCE of 25.25% suggests that Prevest Denpro is effectively utilizing its capital to generate profits. This level of efficiency is a crucial factor in building a sustainable competitive advantage, or a "moat," around the business. Companies with high ROCE can reinvest earnings at attractive rates, fueling future growth and shareholder value creation. This ability to consistently generate high returns makes it harder for competitors to challenge Prevest Denpro's market position. The higher ROCE allows the business to organically grow stronger, making it a leader in certain segments of the dental supplies market.
Comparing Prevest Denpro with its sector peers is essential for a comprehensive assessment. While a detailed comparison requires a deeper dive into the financials of companies like
Choksi Asia, OSEL DEVICES LIMITED, and Transpact Enterprises Ltd, an initial observation suggests that management quality and strategic execution play a significant role in differentiating performance. The efficiency with which Prevest Denpro deploys capital, as reflected in its ROCE, potentially highlights a well-managed operational structure that drives profitability.This analysis is part of a broader 80-parameter fundamental audit of Prevest Denpro Ltd, verified by Sweta Mishra. This audit aims to provide a comprehensive overview of the company's financial health, operational efficiency, and strategic positioning. It is important to remember that this analysis is based on publicly available information and should not be considered financial advice. It is an observational piece, and potential investors should conduct their own thorough research and consult with a qualified financial advisor before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Prevest Denpro Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of PREVEST across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (18.74%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (25.25%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (36.63%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 26.18 vs Industry: 47.87)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (22.80% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (29.49% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Cash Generation (₹26.29 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (73.60%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Weak Earnings Growth (-61.33% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Limited Institutional Interest (FII+DII: 1.38%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Prevest Denpro Ltd Financial Statements
Comprehensive financial data for Prevest Denpro Ltd including income statement, balance sheet and cash flow
About PREVEST (Prevest Denpro Ltd)
Prevest Denpro Ltd (PREVEST) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with a current market capitalisation of ₹521.17 (Cr). Prevest Denpro Ltd has delivered a Return on Equity (ROE) of 18.74% and a ROCE of 25.25%. The debt-to-equity ratio stands at 0.00, reflecting the company's capital structure. Investors tracking PREVEST share price can monitor key metrics including P/E ratio, promoter holding of 73.60%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
Latest News
PREVEST Share Price: Frequently Asked Questions
What is the current share price of Prevest Denpro Ltd (PREVEST)?
As of 19 Feb 2026, 09:13 am IST, Prevest Denpro Ltd share price is ₹462.00. The PREVEST stock has a market capitalisation of ₹521.17 (Cr) on NSE/BSE.
Is PREVEST share price Overvalued or Undervalued?
PREVEST share price is currently trading at a P/E ratio of 26.18x, compared to the industry average of 47.87x. Based on this relative valuation, the Prevest Denpro Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of PREVEST share price?
The 52-week high of PREVEST share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Prevest Denpro Ltd share price?
Key factors influencing PREVEST share price include quarterly earnings growth (Sales Growth: 14.76%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Prevest Denpro Ltd a good stock for long-term investment?
Prevest Denpro Ltd shows a 5-year Profit Growth of 29.49% and an ROE of 18.74%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in PREVEST shares.
How does Prevest Denpro Ltd compare with its industry peers?
Prevest Denpro Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare PREVEST share price P/E of 26.18x and ROE of 18.74% against the industry averages to determine competitive standing.
What is the P/E ratio of PREVEST and what does it mean?
PREVEST share price has a P/E ratio of 26.18x compared to the industry average of 47.87x. Investors pay ₹26 for every ₹1 of annual earnings.
How is PREVEST performing according to Bull Run's analysis?
PREVEST has a Bull Run fundamental score of 68.5/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does PREVEST belong to?
PREVEST operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Prevest Denpro Ltd share price.
What is Return on Equity (ROE) and why is it important for PREVEST?
PREVEST has an ROE of 18.74%, which indicates excellent management efficiency. ROE measures how efficiently Prevest Denpro Ltd generates profits from shareholders capital.
How is PREVEST debt-to-equity ratio and what does it indicate?
PREVEST has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is PREVEST dividend yield and is it a good dividend stock?
PREVEST offers a dividend yield of 0.23%, meaning you receive ₹0.23 annual dividend for every ₹100 invested in Prevest Denpro Ltd shares.
How has PREVEST share price grown over the past 5 years?
PREVEST has achieved 5-year growth rates of: Sales Growth 22.80%, Profit Growth 29.49%, and EPS Growth -61.33%.
What is the promoter holding in PREVEST and why does it matter?
Promoters hold 73.60% of PREVEST shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Prevest Denpro Ltd.
What is PREVEST market capitalisation category?
PREVEST has a market capitalisation of ₹521 crores, placing it in the Small-cap category.
How volatile is PREVEST stock?
PREVEST has a beta of N/A. A beta > 1 suggests the Prevest Denpro Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is PREVEST operating profit margin trend?
PREVEST has a 5-year average Operating Profit Margin (OPM) of 36.63%, indicating the company's operational efficiency.
How is PREVEST quarterly performance?
Recent quarterly performance shows Prevest Denpro Ltd YoY Sales Growth of 14.76% and YoY Profit Growth of 15.08%.
What is the institutional holding pattern in PREVEST?
PREVEST has FII holding of 0.63% and DII holding of 0.75%. Significant institutional holding often suggests professional confidence in the Prevest Denpro Ltd stock.